Institut Claudius Regaud
123
35
40
60
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
11.4%
14 terminated/withdrawn out of 123 trials
81.1%
-5.4% vs industry average
13%
16 trials in Phase 3/4
2%
1 of 60 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (123)
SUrGery With or Without dARolutamide in High-risk and/or Locally Advanced Prostate Cancer
Role: lead
Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated by T-DXd for Locally Advanced or Metastatic Breast Cancer According to Their BMI.
Role: lead
Male breAsT cAncer preDisposition Factor: Creation of a Control Cohort 2
Role: lead
A Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTA0-Tyr3-Octreotate in Children With Refractory or Recurrent Neuroblastoma Expressing Somatostatin Receptors.
Role: lead
Interest of Medical Hypnosis in Anxious Patients Treated by Radiotherapy
Role: lead
Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer
Role: lead
PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
Role: lead
Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival
Role: lead
Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain
Role: lead
Evaluation of the Automatic Deformable Recontouring on the Daily MVCT for Head and Neck Cancer Adaptive Radiotherapy
Role: lead
Cost Utility of Radical Surgery in Ovarian Cancer
Role: lead
Evaluation of an Organized Consultation "Return Home" of Patients With a Cancer (CREDO)
Role: lead
Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis
Role: lead
Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma
Role: lead
Phase I Clinical and Pharmacokinetic Study of Pazopanib in a Population of Frail Elderly Patients According SIOG Criteria
Role: lead
Cilengitide Together With Radiochemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer
Role: lead
Pharmacologic Interaction Between Ifosfamide and Aprepitant in Treated Patients With Soft Tissue Sarcoma
Role: lead
Therapeutic Nipple Sparing Mastectomy.
Role: lead
TNF in Melanoma Patients Treated With Immunotherapy
Role: lead
Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or Not
Role: lead